Alnylam Pharmaceuticals, Inc.
Multi-targeted single entity conjugates

Last updated:

Abstract:

The present invention relates, in general to, compounds, compositions and methods useful for modulating gene expression of multiple target nucleic acids by a single chemical entity.

Status:
Grant
Type:

Utility

Filling date:

15 Jul 2016

Issue date:

6 Jul 2021